Burlington, N.J.—A new published study in the Journal of Functional Foods showed the ability of astaxanthin to significantly lower systolic blood pressure in Zucker fatty rats performed at Georgetown University Medical Center. This study joined three other past studies performed at the Toyama Medical and Pharmaceutical University in Japan which researched astaxanthin’s ability to reduce hypertension as well mechanism of actions for this benefit.
In the Georgetown University study, tests suggested the Renin-Angiotensin System was involved in the ability of astaxanthin to lower blood pressure. Also, at higher dosage levels, astaxanthin influenced circulating TNF-alpha and MCP-1 and lessened fat oxidation in the liver and kidneys. This is an indication that astaxanthin may help to reduce stress.
The study was sponsored by Fuji Chemical Industry Co. LTD of Japan and performed using AstaREAL® astaxanthin.